Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Annmarie Zuardo

Physician Assistant Marietta, GA Physician Assistant

NPI 1891245163 CMS profile 10976040

141 Lacy St Nw Ste 200, Marietta, GA 30060

Open in the dashboard

General payments

$24,607

815 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Annmarie Zuardo of Marietta, GA is reported in the CMS Open Payments database as having received $24,607 across 815 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,180 180
2024 General $4,236 123
2023 General $4,819 182
2022 General $5,217 163
2021 General $4,156 167

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Annmarie Zuardo
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Annmarie Zuardo were reported at $6,180. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Annmarie Zuardo Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $4,156 $132 $37–$438 $132
2022 $5,217 $155 $48–$522 $149
2023 $4,819 $167 $52–$557 $160
2024 $4,236 $178 $55–$600 $164
2025 $6,180 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. UCB, Inc. $3,736 70 payments
  2. Genzyme Corporation $2,665 68 payments
  3. AbbVie, Inc. $2,307 115 payments
  4. Regeneron Healthcare Solutions, Inc. $1,866 58 payments
  5. Novartis Pharmaceuticals Corporation $1,843 67 payments
  6. Arcutis Biotherapeutics, Inc. $1,103 52 payments
  7. Janssen Biotech, Inc. $1,083 55 payments
  8. Sun Pharmaceutical Industries Inc. $1,049 35 payments
  9. Dermavant Sciences, Inc. $1,026 22 payments
  10. E.R. Squibb & Sons, L.L.C. $990 51 payments
  11. Other $6,938 222 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $21,477 800 payments
  2. Consulting Fee $2,280 2 payments
  3. Education $851 13 payments
Products named General payments · program years 2021–2025
  1. Bimzelx $2,880 34 payments
  2. DUPIXENT Immunology $2,787 63 payments
  3. DUPIXENT Inflammation And Immunology $1,328 42 payments
  4. SKYRIZI $1,083 67 payments
  5. VTAMA $1,076 23 payments
  6. SOTYKTU $990 51 payments
  7. TREMFYA $838 36 payments
  8. COSENTYX $777 24 payments
  9. TALTZ $752 34 payments
  10. Xeomin $704 8 payments
  11. Other $12,757 528 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

815 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record